CL2004000400A1 - Compuestos derivados de piridina sustituida con 1,3-oxazol y con isoxazol, composicion farmaceutica, procedimiento de preparacion, utiles como agentes antibacteriano, activo contra la bacteria gram negativa. - Google Patents

Compuestos derivados de piridina sustituida con 1,3-oxazol y con isoxazol, composicion farmaceutica, procedimiento de preparacion, utiles como agentes antibacteriano, activo contra la bacteria gram negativa.

Info

Publication number: CL2004000400A1
Authority: CL; Chile
Prior art keywords: sub; useful; antibacterial agents; piridine; isoxazol
Prior art date: 2003-03-01

Application number

CL200400400A

Other languages

English (en)

Inventor

Michael Barry Carca Gravestock

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-01

Filing date

2004-02-27

Publication date

2005-04-22

2003-03-01 Priority claimed from GB0304723A external-priority patent/GB0304723D0/en

2003-08-08 Priority claimed from GB0318607A external-priority patent/GB0318607D0/en

2004-02-27 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-04-22 Publication of CL2004000400A1 publication Critical patent/CL2004000400A1/es

Links

150000001875 compounds Chemical class 0.000 title abstract 3
239000003242 anti bacterial agent Substances 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
239000008194 pharmaceutical composition Chemical group 0.000 title abstract 2
241000894006 Bacteria Species 0.000 title 1
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical group C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 title 1
AXLOCHLTNQDFFS-BESJYZOMSA-N azastene Chemical group C([C@H]1[C@@H]2CC[C@@]([C@]2(CC[C@@H]1[C@@]1(C)C2)C)(O)C)C=C1C(C)(C)C1=C2C=NO1 AXLOCHLTNQDFFS-BESJYZOMSA-N 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 4
239000001257 hydrogen Substances 0.000 abstract 3
125000003971 isoxazolinyl group Chemical group 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
150000002431 hydrogen Chemical class 0.000 abstract 2
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 2
IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical group O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CL200400400A 2003-03-01 2004-02-27 Compuestos derivados de piridina sustituida con 1,3-oxazol y con isoxazol, composicion farmaceutica, procedimiento de preparacion, utiles como agentes antibacteriano, activo contra la bacteria gram negativa. CL2004000400A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0304723A GB0304723D0 (en)	2003-03-01	2003-03-01	Chemical compounds
GB0318607A GB0318607D0 (en)	2003-08-08	2003-08-08	Chemical compounds

Publications (1)

Publication Number	Publication Date
CL2004000400A1 true CL2004000400A1 (es)	2005-04-22

Family

ID=32964061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200400400A CL2004000400A1 (es)	2003-03-01	2004-02-27	Compuestos derivados de piridina sustituida con 1,3-oxazol y con isoxazol, composicion farmaceutica, procedimiento de preparacion, utiles como agentes antibacteriano, activo contra la bacteria gram negativa.

Country Status (16)

Country	Link
US (1)	US7192974B2 (es)
EP (1)	EP1599471B1 (es)
JP (1)	JP2006519247A (es)
KR (1)	KR20050106064A (es)
AT (1)	ATE396991T1 (es)
AU (1)	AU2004218206A1 (es)
BR (1)	BRPI0407835A (es)
CA (1)	CA2517706A1 (es)
CL (1)	CL2004000400A1 (es)
DE (1)	DE602004014107D1 (es)
ES (1)	ES2305732T3 (es)
MX (1)	MXPA05009205A (es)
NO (1)	NO20054523L (es)
TW (1)	TW200500360A (es)
UY (1)	UY28211A1 (es)
WO (1)	WO2004078753A1 (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2248633T3 (es) *	2001-04-17	2006-03-16	MERCK & CO., INC.	Antibioticos oxazolidinona que contienen biciclo (3,1,o)hexano y derivados de los mismos.
WO2003072576A2 (en)	2002-02-28	2003-09-04	Astrazeneca Ab	Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
NZ535592A (en)	2002-02-28	2006-07-28	Astrazeneca Ab	3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
WO2005012271A2 (en) *	2003-07-29	2005-02-10	Rib-X Pharmaceuticals, Inc.	Process for the synthesis of biaryl oxazolidinones
TWI378092B (en) *	2003-06-03	2012-12-01	Rib X Pharmaceuticals Inc	Biaryl heterocyclic compounds and methods of making and using the same
US8324398B2 (en)	2003-06-03	2012-12-04	Rib-X Pharmaceuticals, Inc.	Process for the synthesis of biaryl oxazolidinones
AU2004256085B2 (en) *	2003-07-02	2007-12-06	Kyorin, Pharmaceutical Co., Ltd.	Cyclopropyl Group Substituted Oxazolydinone Antibiotics and Derivatives Thereof
CA2529292A1 (en) *	2003-07-02	2005-01-20	Merck & Co., Inc.	Oxazolidinone antibiotics and derivatives thereof
MXPA06000228A (es) *	2003-07-02	2006-06-27	Merck & Co Inc	Antibioticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos.
US20070293493A1 (en) *	2003-07-02	2007-12-20	Milton Hammond	Oxazolidinone antibiotics and derivatives thereof
JP4777246B2 (ja) *	2003-07-29	2011-09-21	リブ−エックスファーマシューティカルズ，インコーポレイテッド	ビアリールオキサゾリジノンの合成方法
US7932272B2 (en)	2003-09-30	2011-04-26	Eisai R&D Management Co., Ltd.	Antifungal agent containing heterocyclic compound
JP2007514782A (ja)	2003-12-17	2007-06-07	リブ−エックスファーマシューティカルズ，インコーポレイテッド	ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
KR100854211B1 (ko)	2003-12-18	2008-08-26	동아제약주식회사	신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US20050241110A1 (en) *	2004-04-09	2005-11-03	Bruce Baker	Ergonomic handles, especially for garden tools
US20070208062A1 (en) *	2004-05-25	2007-09-06	Astrazeneca Ab	3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
GB0411596D0 (en) *	2004-05-25	2004-06-30	Astrazeneca Ab	Chemical process
US20080064689A1 (en) *	2004-05-25	2008-03-13	Astrazeneca Ab	3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
US20100286211A1 (en) *	2004-10-08	2010-11-11	Biswajit Das	Oxazolidinone derivatives as antimicrobials
WO2006106711A1 (ja)	2005-03-30	2006-10-12	Eisai R & D Management Co., Ltd.	ピリジン誘導体を含有する抗真菌剤
EP1904489B1 (en)	2005-06-08	2011-01-26	Rib-X Pharmaceuticals, Inc.	Process for the synthesis of triazoles
TWI385169B (zh)	2005-10-31	2013-02-11	Eisai R&D Man Co Ltd	經雜環取代之吡啶衍生物及含有彼之抗真菌劑
EP1946840B1 (en) *	2005-11-04	2019-08-21	NGK Insulators, Ltd.	Honeycomb structure and honeycomb catalyst
US8119667B2 (en) *	2005-12-29	2012-02-21	Schering-Plough Animal Health Corporation	Carbonates of fenicol antibiotics
WO2008035726A1 (en)	2006-09-21	2008-03-27	Eisai R & D Management Co., Ltd.	Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
US20080190341A1 (en) *	2007-02-08	2008-08-14	Baruh Bradford G	System and method of adjusting the location and position of the foresail on a sailboat
US20100065104A1 (en) *	2007-08-31	2010-03-18	Baruh Bradford G	Retractable solar panel system
US8258394B2 (en) *	2007-02-08	2012-09-04	Bradford G Baruh	Retractable solar panel system
KR100848232B1 (ko) *	2007-04-12	2008-07-24	일동제약주식회사	신규 헤테로 고리 또는 알콕시아미노메틸 옥사졸리디논 및그 제조방법
TW200841879A (en) *	2007-04-27	2008-11-01	Eisai R&D Man Co Ltd	Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
CN101622251B (zh)	2007-04-27	2012-07-04	卫材R&D管理有限公司	杂环取代吡啶衍生物的盐或其结晶
CA2726420C (en) *	2007-06-01	2018-07-31	Chx Technologies, Inc.	Topical dental solution of chlorhexidine in sumatra benzoin bp/ep and methods of manufacturing and evaluating same for compliance with international regulatory specifications
US8513287B2 (en)	2007-12-27	2013-08-20	Eisai R&D Management Co., Ltd.	Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US20100048524A1 (en)	2008-03-14	2010-02-25	Angela Brodie	Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
WO2009120565A2 (en)	2008-03-25	2009-10-01	University Of Maryland, Baltimore	Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
CN101965353B (zh)	2008-03-26	2014-12-17	丹诺医药(苏州）有限公司	共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
RU2659792C1 (ru)	2008-10-10	2018-07-04	Мерк Шарп Энд Домэ Корп.	Оксазолидиноны и способ их очистки
US8188119B2 (en) *	2008-10-24	2012-05-29	Eisai R&D Management Co., Ltd	Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
MX384300B (es)	2009-02-03	2025-03-14	Merck Sharp & Dohme Llc	Forma cristalina del fosfato de dihidrogeno r) -3- (4- (2- (2-metiltetrazol-5-il) piridin-5-il) -3-fluorofenil) -5-hidroximetil oxazolidin-2-ona.
EP2393827B1 (en)	2009-02-05	2015-10-07	Tokai Pharmaceuticals, Inc.	Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
KR20110136850A (ko) *	2009-03-13	2011-12-21	썬 케미칼 비.브이.	에너지-경화성 조성물에 유용한 사이클릭 카바메이트 화합물
US8580767B2 (en) *	2009-05-28	2013-11-12	Trius Therapeutics, Inc.	Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101653570B1 (ko) *	2011-03-30	2016-09-02	주식회사 레고켐 바이오사이언스	신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
EP2626356A1 (en) *	2012-02-08	2013-08-14	Rheinische Friedrich-Wilhelms-Universität Bonn	Thiamine analogues and their use as antibiotics
CA2904170A1 (en)	2013-03-14	2014-09-25	University Of Maryland, Baltimore	Androgen receptor down-regulating agents and uses thereof
KR20160058774A (ko)	2013-08-12	2016-05-25	토카이 파마슈티컬, 아이엔씨.	안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커
WO2021000297A1 (en)	2019-07-03	2021-01-07	Merck Sharp & Dohme Corp.	Compounds and methods of use thereof as antibacterial agents
CN112707779B (zh) *	2020-12-26	2023-06-30	蚌埠中实化学技术有限公司	一种乙烯基环己烷的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4948801A (en) *	1988-07-29	1990-08-14	E. I. Du Pont De Nemours And Company	Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
EP0610265B1 (en) *	1991-11-01	1996-12-27	PHARMACIA & UPJOHN COMPANY	Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
NZ522990A (en) *	2000-06-05	2003-08-29	Dong A Pharm	Novel oxazolidinone derivatives and a process for the preparation thereof
US20020115669A1 (en)	2000-08-31	2002-08-22	Wiedeman Paul E.	Oxazolidinone chemotherapeutic agents
AU2002329393B2 (en) *	2001-09-11	2008-06-12	Astrazeneca Ab	Oxazolidinone and/or isoxazoline as antibacterial agents
NZ540147A (en) *	2002-11-28	2008-03-28	Astrazeneca Ab	Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
GB0227701D0 (en) *	2002-11-28	2003-01-08	Astrazeneca Ab	Chemical compounds
GB0229526D0 (en) *	2002-12-19	2003-01-22	Astrazeneca Ab	Chemical compounds

2004
- 2004-02-23 TW TW093104447A patent/TW200500360A/zh unknown
- 2004-02-24 DE DE602004014107T patent/DE602004014107D1/de not_active Expired - Fee Related
- 2004-02-24 CA CA002517706A patent/CA2517706A1/en not_active Abandoned
- 2004-02-24 MX MXPA05009205A patent/MXPA05009205A/es not_active Application Discontinuation
- 2004-02-24 KR KR1020057016202A patent/KR20050106064A/ko not_active Withdrawn
- 2004-02-24 ES ES04713945T patent/ES2305732T3/es not_active Expired - Lifetime
- 2004-02-24 US US10/546,373 patent/US7192974B2/en not_active Expired - Fee Related
- 2004-02-24 JP JP2006505893A patent/JP2006519247A/ja active Pending
- 2004-02-24 WO PCT/GB2004/000730 patent/WO2004078753A1/en not_active Ceased
- 2004-02-24 BR BRPI0407835-7A patent/BRPI0407835A/pt not_active IP Right Cessation
- 2004-02-24 AU AU2004218206A patent/AU2004218206A1/en not_active Abandoned
- 2004-02-24 EP EP04713945A patent/EP1599471B1/en not_active Expired - Lifetime
- 2004-02-24 AT AT04713945T patent/ATE396991T1/de not_active IP Right Cessation
- 2004-02-27 UY UY28211A patent/UY28211A1/es not_active Application Discontinuation
- 2004-02-27 CL CL200400400A patent/CL2004000400A1/es unknown
2005
- 2005-09-30 NO NO20054523A patent/NO20054523L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2517706A1 (en)	2004-09-16
EP1599471B1 (en)	2008-05-28
HK1083097A1 (en)	2006-06-23
US7192974B2 (en)	2007-03-20
KR20050106064A (ko)	2005-11-08
TW200500360A (en)	2005-01-01
MXPA05009205A (es)	2005-10-18
JP2006519247A (ja)	2006-08-24
AU2004218206A1 (en)	2004-09-16
DE602004014107D1 (de)	2008-07-10
NO20054523D0 (no)	2005-09-30
US20060270637A1 (en)	2006-11-30
UY28211A1 (es)	2004-09-30
BRPI0407835A (pt)	2006-02-14
NO20054523L (no)	2005-12-01
ES2305732T3 (es)	2008-11-01
ATE396991T1 (de)	2008-06-15
EP1599471A1 (en)	2005-11-30
WO2004078753A1 (en)	2004-09-16

Publication	Publication Date	Title
UY28211A1 (es)	2004-09-30	Compuestos de hidroximetilo
MX2023013978A (es)	2023-12-12	Composicion fungicida que contiene compuestos de oxadiazol.
PE20060242A1 (es)	2006-03-31	Heterociclicos biciclicos como inhibidores de la integrasa del vih
WO2007023507A3 (en)	2007-07-12	Oxazolidinones bearing antimicrobial activity composition and methods of preparation
EA200600225A1 (ru)	2006-08-25	Производные пиперазина для лечения вич инфекций
EP1361220A4 (en)	2005-09-07	CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM
GEP20094675B (en)	2009-05-10	Heteroaryl- tetra-hydropiperidyl compounds useful for treating or preventing pain
WO2022106469A3 (en)	2022-08-11	N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections
EA200601896A1 (ru)	2007-02-27	Производные пролина и их применение в качестве ингибиторов дипептидилпептидазы iv
NO20083207L (no)	2008-09-17	Inhibitorer av IAP
RU2010101004A (ru)	2011-07-20	Новые микробиоциды
RU2450015C2 (ru)	2012-05-10	Производные аминотиазола и их применение в качестве антибактериальных средств
BR0213140A (pt)	2004-10-19	Fungicidas de pirazol-pirimidina
AP2003002942A0 (en)	2003-12-24	New derivatives of oxazolidinones as bacterial agents
MX2021011286A (es)	2022-01-24	Compuestos de heterociclil(fenil)metanol útiles en el tratamiento de la hiperglucemia.
EA200970534A1 (ru)	2009-10-30	Антибактериальные производные хинолина
NO20052074L (no)	2005-06-01	Substituerte benzoksazinoner og anvendelser derav.
NO20075617L (no)	2007-12-03	4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet
WO2005003087A3 (en)	2005-03-17	Oxazole derivatives as antibacterial agents
PE20221486A1 (es)	2022-09-26	Tieniloxazolonas y analogos
PE20080283A1 (es)	2008-04-10	Profarmacos antimicrobianos de oxazolidinona
NO20070870L (no)	2007-04-16	Oksazolidinonforbindelser og sammensetninger og fremgangsmater relatert dertil
MX2013011272A (es)	2014-03-21	Derivado de oxazolidinona novedoso y composicion farmaceutica que incluye el mismo.
TW200740800A (en)	2007-11-01	Oxazolidinone compounds, and compositions and methods related thereto
WO2003072576A3 (en)	2003-12-31	Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them